FUJIFILM Holdings Corporation

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SEMHF has a market cap of 45.3B. Regarding current trading prices, FUJIF is priced at $20.00, while SEMHF trades at $41.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SEMHF's P/E ratio is 18.39. In terms of profitability, FUJIF's ROE is +0.10%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, FUJIF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check SEMHF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, RSMDF has a market cap of 26B. Regarding current trading prices, FUJIF is priced at $20.00, while RSMDF trades at $17.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas RSMDF's P/E ratio is 17.24. In terms of profitability, FUJIF's ROE is +0.10%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, FUJIF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check RSMDF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, RYLPF has a market cap of 25.7B. Regarding current trading prices, FUJIF is priced at $20.00, while RYLPF trades at $26.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas RYLPF's P/E ratio is 23.26. In terms of profitability, FUJIF's ROE is +0.10%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, FUJIF and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, FUJIY has a market cap of 24.2B. Regarding current trading prices, FUJIF is priced at $20.00, while FUJIY trades at $10.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas FUJIY's P/E ratio is 14.11. In terms of profitability, FUJIF's ROE is +0.10%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, FUJIF is less volatile compared to FUJIY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check FUJIY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SMMNY has a market cap of 22.7B. Regarding current trading prices, FUJIF is priced at $20.00, while SMMNY trades at $20.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SMMNY's P/E ratio is 18.49. In terms of profitability, FUJIF's ROE is +0.10%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, FUJIF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check SMMNY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SONVF has a market cap of 15.9B. Regarding current trading prices, FUJIF is priced at $20.00, while SONVF trades at $268.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SONVF's P/E ratio is 23.43. In terms of profitability, FUJIF's ROE is +0.10%, compared to SONVF's ROE of +0.21%. Regarding short-term risk, FUJIF and SONVF have similar daily volatility (0.00).Check SONVF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SONVY has a market cap of 15.8B. Regarding current trading prices, FUJIF is priced at $20.00, while SONVY trades at $52.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SONVY's P/E ratio is 23.25. In terms of profitability, FUJIF's ROE is +0.10%, compared to SONVY's ROE of +0.22%. Regarding short-term risk, FUJIF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check SONVY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CLPBY has a market cap of 14.3B. Regarding current trading prices, FUJIF is priced at $20.00, while CLPBY trades at $6.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CLPBY's P/E ratio is 42.27. In terms of profitability, FUJIF's ROE is +0.10%, compared to CLPBY's ROE of +0.14%. Regarding short-term risk, FUJIF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CLPBY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CLPBF has a market cap of 12.7B. Regarding current trading prices, FUJIF is priced at $20.00, while CLPBF trades at $61.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CLPBF's P/E ratio is 42.32. In terms of profitability, FUJIF's ROE is +0.10%, compared to CLPBF's ROE of +0.14%. Regarding short-term risk, FUJIF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CLPBF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, FUJIF is priced at $20.00, while SNNUF trades at $14.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SNNUF's P/E ratio is 20.71. In terms of profitability, FUJIF's ROE is +0.10%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, FUJIF is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check SNNUF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, OCPNF has a market cap of 12.3B. Regarding current trading prices, FUJIF is priced at $20.00, while OCPNF trades at $11.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas OCPNF's P/E ratio is 29.42. In terms of profitability, FUJIF's ROE is +0.10%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, FUJIF and OCPNF have similar daily volatility (0.00).Check OCPNF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, WILYY has a market cap of 8.2B. Regarding current trading prices, FUJIF is priced at $20.00, while WILYY trades at $18.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas WILYY's P/E ratio is 22.22. In terms of profitability, FUJIF's ROE is +0.10%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, FUJIF and WILYY have similar daily volatility (0.00).Check WILYY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, FUJIF is priced at $20.00, while WILLF trades at $35.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas WILLF's P/E ratio is 20.37. In terms of profitability, FUJIF's ROE is +0.10%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, FUJIF and WILLF have similar daily volatility (0.00).Check WILLF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, GNGBY has a market cap of 5.6B. Regarding current trading prices, FUJIF is priced at $20.00, while GNGBY trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas GNGBY's P/E ratio is 22.18. In terms of profitability, FUJIF's ROE is +0.10%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, FUJIF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check GNGBY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, FUJIF is priced at $20.00, while GNGBF trades at $20.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas GNGBF's P/E ratio is 21.79. In terms of profitability, FUJIF's ROE is +0.10%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, FUJIF and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, YPHDF has a market cap of 4.7B. Regarding current trading prices, FUJIF is priced at $20.00, while YPHDF trades at $354.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas YPHDF's P/E ratio is 17.15. In terms of profitability, FUJIF's ROE is +0.10%, compared to YPHDF's ROE of +0.38%. Regarding short-term risk, FUJIF and YPHDF have similar daily volatility (0.00).Check YPHDF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CHEOY has a market cap of 4.6B. Regarding current trading prices, FUJIF is priced at $20.00, while CHEOY trades at $35.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CHEOY's P/E ratio is 18.61. In terms of profitability, FUJIF's ROE is +0.10%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, FUJIF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CHEOY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CHEOF has a market cap of 4.4B. Regarding current trading prices, FUJIF is priced at $20.00, while CHEOF trades at $67.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CHEOF's P/E ratio is 17.85. In terms of profitability, FUJIF's ROE is +0.10%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, FUJIF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CHEOF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, NHNKY has a market cap of 2.9B. Regarding current trading prices, FUJIF is priced at $20.00, while NHNKY trades at $9.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas NHNKY's P/E ratio is 16.21. In terms of profitability, FUJIF's ROE is +0.10%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, FUJIF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check NHNKY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, AMBBY has a market cap of 2.7B. Regarding current trading prices, FUJIF is priced at $20.00, while AMBBY trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas AMBBY's P/E ratio is 36.43. In terms of profitability, FUJIF's ROE is +0.10%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, FUJIF is less volatile compared to AMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check AMBBY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, AMFPF has a market cap of 2.6B. Regarding current trading prices, FUJIF is priced at $20.00, while AMFPF trades at $12.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas AMFPF's P/E ratio is 33.36. In terms of profitability, FUJIF's ROE is +0.10%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, FUJIF and AMFPF have similar daily volatility (0.00).Check AMFPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, AMBFF has a market cap of 2.6B. Regarding current trading prices, FUJIF is priced at $20.00, while AMBFF trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas AMBFF's P/E ratio is 35.36. In terms of profitability, FUJIF's ROE is +0.10%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, FUJIF and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, FUJIF is priced at $20.00, while GNNDY trades at $45.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas GNNDY's P/E ratio is 54.23. In terms of profitability, FUJIF's ROE is +0.10%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, FUJIF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check GNNDY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, FUJIF is priced at $20.00, while MCRPF trades at $1.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, FUJIF's ROE is +0.10%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, FUJIF and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, FUJIF is priced at $20.00, while GGNDF trades at $14.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas GGNDF's P/E ratio is 52.14. In terms of profitability, FUJIF's ROE is +0.10%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, FUJIF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check GGNDF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, FUJIF is priced at $20.00, while DRWKF trades at $111.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas DRWKF's P/E ratio is 11.78. In terms of profitability, FUJIF's ROE is +0.10%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, FUJIF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check DRWKF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, FUJIF is priced at $20.00, while OSSFF trades at $4.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, FUJIF's ROE is +0.10%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, FUJIF and OSSFF have similar daily volatility (0.00).Check OSSFF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, OSSUY has a market cap of 1.8B. Regarding current trading prices, FUJIF is priced at $20.00, while OSSUY trades at $4.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas OSSUY's P/E ratio is 20.65. In terms of profitability, FUJIF's ROE is +0.10%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, FUJIF and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, FUJIF is priced at $20.00, while DWRKF trades at $543.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, FUJIF's ROE is +0.10%, compared to DWRKF's ROE of N/A. Regarding short-term risk, FUJIF and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, FUJIF is priced at $20.00, while NHNKF trades at $10.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, FUJIF's ROE is +0.10%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, FUJIF and NHNKF have similar daily volatility (0.00).Check NHNKF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, FUJIF is priced at $20.00, while MEDGF trades at $83.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, FUJIF's ROE is +0.10%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, FUJIF and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, FUJIF is priced at $20.00, while BOEUF trades at $24.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas BOEUF's P/E ratio is 83.30. In terms of profitability, FUJIF's ROE is +0.10%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, FUJIF is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check BOEUF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, FUJIF is priced at $20.00, while VTRLY trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas VTRLY's P/E ratio is -2.78. In terms of profitability, FUJIF's ROE is +0.10%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, FUJIF and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, FUJIF is priced at $20.00, while MDRSF trades at $115.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, FUJIF's ROE is +0.10%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, FUJIF and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, FUJIF is priced at $20.00, while DGWPF trades at $72.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas DGWPF's P/E ratio is 7.59. In terms of profitability, FUJIF's ROE is +0.10%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, FUJIF and DGWPF have similar daily volatility (0.00).Check DGWPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, FDMDF has a market cap of 1.3B. Regarding current trading prices, FUJIF is priced at $20.00, while FDMDF trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas FDMDF's P/E ratio is -7.76. In terms of profitability, FUJIF's ROE is +0.10%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, FUJIF and FDMDF have similar daily volatility (0.00).Check FDMDF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, FUJIF is priced at $20.00, while ELEAF trades at $15.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ELEAF's P/E ratio is 20.69. In terms of profitability, FUJIF's ROE is +0.10%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, FUJIF and ELEAF have similar daily volatility (0.00).Check ELEAF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, XVIPF has a market cap of 925.8M. Regarding current trading prices, FUJIF is priced at $20.00, while XVIPF trades at $29.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas XVIPF's P/E ratio is 117.56. In terms of profitability, FUJIF's ROE is +0.10%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, FUJIF and XVIPF have similar daily volatility (0.00).Check XVIPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, FUJIF is priced at $20.00, while LFTSF trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, FUJIF's ROE is +0.10%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, FUJIF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check LFTSF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, BRSYF has a market cap of 674.4M. Regarding current trading prices, FUJIF is priced at $20.00, while BRSYF trades at $16.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas BRSYF's P/E ratio is 76.55. In terms of profitability, FUJIF's ROE is +0.10%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, FUJIF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check BRSYF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CALZF has a market cap of 529.4M. Regarding current trading prices, FUJIF is priced at $20.00, while CALZF trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CALZF's P/E ratio is 76.62. In terms of profitability, FUJIF's ROE is +0.10%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, FUJIF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CALZF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, IOBCF has a market cap of 528.5M. Regarding current trading prices, FUJIF is priced at $20.00, while IOBCF trades at $18.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas IOBCF's P/E ratio is 36.78. In terms of profitability, FUJIF's ROE is +0.10%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, FUJIF is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check IOBCF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, FUJIF is priced at $20.00, while AVMR trades at $9.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas AVMR's P/E ratio is -18.34. In terms of profitability, FUJIF's ROE is +0.10%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, FUJIF and AVMR have similar daily volatility (0.00).Check AVMR's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, FUJIF is priced at $20.00, while HYBT trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas HYBT's P/E ratio is N/A. In terms of profitability, FUJIF's ROE is +0.10%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, FUJIF and HYBT have similar daily volatility (0.00).Check HYBT's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, FUJIF is priced at $20.00, while CLVSF trades at $13.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CLVSF's P/E ratio is 22.48. In terms of profitability, FUJIF's ROE is +0.10%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, FUJIF and CLVSF have similar daily volatility (0.00).Check CLVSF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CYBQY has a market cap of 294.3M. Regarding current trading prices, FUJIF is priced at $20.00, while CYBQY trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CYBQY's P/E ratio is -165.00. In terms of profitability, FUJIF's ROE is +0.10%, compared to CYBQY's ROE of +0.01%. Regarding short-term risk, FUJIF and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, FUJIF is priced at $20.00, while CSSPF trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, FUJIF's ROE is +0.10%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, FUJIF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CSSPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, DMTRF has a market cap of 270.5M. Regarding current trading prices, FUJIF is priced at $20.00, while DMTRF trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas DMTRF's P/E ratio is -112.50. In terms of profitability, FUJIF's ROE is +0.10%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, FUJIF and DMTRF have similar daily volatility (0.00).Check DMTRF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CYBQF has a market cap of 246.8M. Regarding current trading prices, FUJIF is priced at $20.00, while CYBQF trades at $1.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CYBQF's P/E ratio is -185.00. In terms of profitability, FUJIF's ROE is +0.10%, compared to CYBQF's ROE of +0.00%. Regarding short-term risk, FUJIF is less volatile compared to CYBQF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check CYBQF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, FUJIF is priced at $20.00, while HTLZF trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, FUJIF's ROE is +0.10%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, FUJIF and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, FUJIF is priced at $20.00, while IMPZY trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, FUJIF's ROE is +0.10%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, FUJIF and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, EBRCZ has a market cap of 227M. Regarding current trading prices, FUJIF is priced at $20.00, while EBRCZ trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas EBRCZ's P/E ratio is -1.38. In terms of profitability, FUJIF's ROE is +0.10%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, FUJIF and EBRCZ have similar daily volatility (0.00).Check EBRCZ's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, XVIPY has a market cap of 206M. Regarding current trading prices, FUJIF is priced at $20.00, while XVIPY trades at $6.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas XVIPY's P/E ratio is N/A. In terms of profitability, FUJIF's ROE is +0.10%, compared to XVIPY's ROE of +0.01%. Regarding short-term risk, FUJIF and XVIPY have similar daily volatility (0.00).Check XVIPY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, FUJIF is priced at $20.00, while VMTHF trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, FUJIF's ROE is +0.10%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, FUJIF and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, FUJIF is priced at $20.00, while DTXMF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, FUJIF's ROE is +0.10%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, FUJIF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check DTXMF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CLLKF has a market cap of 157.5M. Regarding current trading prices, FUJIF is priced at $20.00, while CLLKF trades at $2.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CLLKF's P/E ratio is -1.02. In terms of profitability, FUJIF's ROE is +0.10%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, FUJIF and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, JMDMF has a market cap of 156.4M. Regarding current trading prices, FUJIF is priced at $20.00, while JMDMF trades at $5.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas JMDMF's P/E ratio is -22.73. In terms of profitability, FUJIF's ROE is +0.10%, compared to JMDMF's ROE of N/A. Regarding short-term risk, FUJIF and JMDMF have similar daily volatility (0.00).Check JMDMF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, EKDHF has a market cap of 149.3M. Regarding current trading prices, FUJIF is priced at $20.00, while EKDHF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas EKDHF's P/E ratio is 34.69. In terms of profitability, FUJIF's ROE is +0.10%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, FUJIF and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, EAPIF has a market cap of 147.5M. Regarding current trading prices, FUJIF is priced at $20.00, while EAPIF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas EAPIF's P/E ratio is -0.60. In terms of profitability, FUJIF's ROE is +0.10%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, FUJIF and EAPIF have similar daily volatility (0.00).Check EAPIF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, BCCOY has a market cap of 145.1M. Regarding current trading prices, FUJIF is priced at $20.00, while BCCOY trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas BCCOY's P/E ratio is -0.92. In terms of profitability, FUJIF's ROE is +0.10%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, FUJIF and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, FUJIF is priced at $20.00, while AMEUF trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, FUJIF's ROE is +0.10%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, FUJIF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check AMEUF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, FUJIF is priced at $20.00, while PXMBF trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, FUJIF's ROE is +0.10%, compared to PXMBF's ROE of -0.03%. Regarding short-term risk, FUJIF is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check PXMBF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, FUJIF is priced at $20.00, while SOMNF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, FUJIF's ROE is +0.10%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, FUJIF and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, FUJIF is priced at $20.00, while RSHUF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, FUJIF's ROE is +0.10%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, FUJIF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check RSHUF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, AVHHL has a market cap of 90.1M. Regarding current trading prices, FUJIF is priced at $20.00, while AVHHL trades at $0.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas AVHHL's P/E ratio is -2.34. In terms of profitability, FUJIF's ROE is +0.10%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, FUJIF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check AVHHL's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, FUJIF is priced at $20.00, while CKMTF trades at $12.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, FUJIF's ROE is +0.10%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, FUJIF and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, FUJIF is priced at $20.00, while SNZZF trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas SNZZF's P/E ratio is -5.30. In terms of profitability, FUJIF's ROE is +0.10%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, FUJIF and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, BLOZF has a market cap of 61.7M. Regarding current trading prices, FUJIF is priced at $20.00, while BLOZF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas BLOZF's P/E ratio is -12.57. In terms of profitability, FUJIF's ROE is +0.10%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, FUJIF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check BLOZF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, TLTFF has a market cap of 45.9M. Regarding current trading prices, FUJIF is priced at $20.00, while TLTFF trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas TLTFF's P/E ratio is -16.65. In terms of profitability, FUJIF's ROE is +0.10%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, FUJIF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check TLTFF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, FUJIF is priced at $20.00, while BRNHF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, FUJIF's ROE is +0.10%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, FUJIF and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ACIXF has a market cap of 35M. Regarding current trading prices, FUJIF is priced at $20.00, while ACIXF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ACIXF's P/E ratio is -3.11. In terms of profitability, FUJIF's ROE is +0.10%, compared to ACIXF's ROE of -1.06%. Regarding short-term risk, FUJIF and ACIXF have similar daily volatility (0.00).Check ACIXF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, FUJIF is priced at $20.00, while NVYTF trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, FUJIF's ROE is +0.10%, compared to NVYTF's ROE of -1.22%. Regarding short-term risk, FUJIF and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, RDGL has a market cap of 33.6M. Regarding current trading prices, FUJIF is priced at $20.00, while RDGL trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas RDGL's P/E ratio is -6.81. In terms of profitability, FUJIF's ROE is +0.10%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, FUJIF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check RDGL's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, PYNKF has a market cap of 25.9M. Regarding current trading prices, FUJIF is priced at $20.00, while PYNKF trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas PYNKF's P/E ratio is 4.11. In terms of profitability, FUJIF's ROE is +0.10%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, FUJIF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check PYNKF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, FUJIF is priced at $20.00, while MKEAF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, FUJIF's ROE is +0.10%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, FUJIF and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, POSC has a market cap of 25.6M. Regarding current trading prices, FUJIF is priced at $20.00, while POSC trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas POSC's P/E ratio is -5.42. In terms of profitability, FUJIF's ROE is +0.10%, compared to POSC's ROE of -7.67%. Regarding short-term risk, FUJIF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check POSC's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, FUJIF is priced at $20.00, while TCLIF trades at $0.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, FUJIF's ROE is +0.10%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, FUJIF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check TCLIF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, FUJIF is priced at $20.00, while KBBTF trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, FUJIF's ROE is +0.10%, compared to KBBTF's ROE of N/A. Regarding short-term risk, FUJIF and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, FUJIF is priced at $20.00, while EMITF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas EMITF's P/E ratio is -7.62. In terms of profitability, FUJIF's ROE is +0.10%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, FUJIF and EMITF have similar daily volatility (0.00).Check EMITF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, VPTDF has a market cap of 18.4M. Regarding current trading prices, FUJIF is priced at $20.00, while VPTDF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas VPTDF's P/E ratio is -9.80. In terms of profitability, FUJIF's ROE is +0.10%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, FUJIF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check VPTDF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, FUJIF is priced at $20.00, while DIZTF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, FUJIF's ROE is +0.10%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, FUJIF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check DIZTF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, GTHP has a market cap of 17.6M. Regarding current trading prices, FUJIF is priced at $20.00, while GTHP trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas GTHP's P/E ratio is -5.72. In terms of profitability, FUJIF's ROE is +0.10%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, FUJIF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check GTHP's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, FUJIF is priced at $20.00, while MDXHF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, FUJIF's ROE is +0.10%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, FUJIF and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, IPDQF has a market cap of 14.3M. Regarding current trading prices, FUJIF is priced at $20.00, while IPDQF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas IPDQF's P/E ratio is -0.70. In terms of profitability, FUJIF's ROE is +0.10%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, FUJIF and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, FUJIF is priced at $20.00, while TMDIF trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, FUJIF's ROE is +0.10%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, FUJIF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check TMDIF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ASAPF has a market cap of 13.7M. Regarding current trading prices, FUJIF is priced at $20.00, while ASAPF trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ASAPF's P/E ratio is -17.51. In terms of profitability, FUJIF's ROE is +0.10%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, FUJIF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check ASAPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, FUJIF is priced at $20.00, while ATBPF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, FUJIF's ROE is +0.10%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, FUJIF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check ATBPF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, FUJIF is priced at $20.00, while LXXGF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, FUJIF's ROE is +0.10%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, FUJIF and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ALRTF has a market cap of 9.7M. Regarding current trading prices, FUJIF is priced at $20.00, while ALRTF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ALRTF's P/E ratio is -0.37. In terms of profitability, FUJIF's ROE is +0.10%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, FUJIF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check ALRTF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, FUJIF is priced at $20.00, while PLLWF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, FUJIF's ROE is +0.10%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, FUJIF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check PLLWF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, BIEL has a market cap of 7.2M. Regarding current trading prices, FUJIF is priced at $20.00, while BIEL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas BIEL's P/E ratio is N/A. In terms of profitability, FUJIF's ROE is +0.10%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, FUJIF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check BIEL's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, PMEDF has a market cap of 6.2M. Regarding current trading prices, FUJIF is priced at $20.00, while PMEDF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas PMEDF's P/E ratio is -3.00. In terms of profitability, FUJIF's ROE is +0.10%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, FUJIF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check PMEDF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, FUJIF is priced at $20.00, while QLIS trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas QLIS's P/E ratio is 2.22. In terms of profitability, FUJIF's ROE is +0.10%, compared to QLIS's ROE of -0.15%. Regarding short-term risk, FUJIF and QLIS have similar daily volatility (0.00).Check QLIS's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, FUJIF is priced at $20.00, while RHNMF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, FUJIF's ROE is +0.10%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, FUJIF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check RHNMF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, LLBO has a market cap of 4.3M. Regarding current trading prices, FUJIF is priced at $20.00, while LLBO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas LLBO's P/E ratio is N/A. In terms of profitability, FUJIF's ROE is +0.10%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, FUJIF is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check LLBO's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, USAQ has a market cap of 4.1M. Regarding current trading prices, FUJIF is priced at $20.00, while USAQ trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas USAQ's P/E ratio is 11.17. In terms of profitability, FUJIF's ROE is +0.10%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, FUJIF and USAQ have similar daily volatility (0.00).Check USAQ's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ELXMF has a market cap of 4.1M. Regarding current trading prices, FUJIF is priced at $20.00, while ELXMF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ELXMF's P/E ratio is -0.72. In terms of profitability, FUJIF's ROE is +0.10%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, FUJIF and ELXMF have similar daily volatility (0.00).Check ELXMF's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, ADMT has a market cap of 3.8M. Regarding current trading prices, FUJIF is priced at $20.00, while ADMT trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas ADMT's P/E ratio is -5.60. In terms of profitability, FUJIF's ROE is +0.10%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, FUJIF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for FUJIF.Check ADMT's competition here

FUJIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FUJIF stands at 23.9B. In comparison, NGMDF has a market cap of 3.7M. Regarding current trading prices, FUJIF is priced at $20.00, while NGMDF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FUJIF currently has a P/E ratio of 14.18, whereas NGMDF's P/E ratio is -0.55. In terms of profitability, FUJIF's ROE is +0.10%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, FUJIF and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here